Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product ...( Experienced Medical Device Executiv...)

Experienced Medical Device Executive and Former CFO of Thermage Inc. To Drive Coapt's Growth In New Markets, Including Non-Invasive Aesthetics

PALO ALTO, Calif., June 13 /PRNewswire/ -- Coapt Systems, Inc., developer of bioabsorbable implants for the fixation of soft tissue in the plastic, reconstructive and sports medicine markets, announced today the appointment of Laureen DeBuono as its President and CEO. She will also serve as a member of the company's Board of Directors. DeBuono has more than 25 years of management experience in the medical device and technology markets. She was most recently CFO of Thermage, Inc., one of the leading medical device companies for aesthetic applications, where she was instrumental in building its growth platform and taking the company public in November 2006. At Coapt Systems, DeBuono will focus on growing core product revenue, building the technology platform, and expanding into new markets, including non-invasive aesthetics.

(Photo: http://www.newscom.com/cgi-bin/prnh/20080613/AQF014)

"I am thrilled to join Coapt Systems as its President and CEO and to help the company achieve even greater success by taking advantage of new market opportunities," said DeBuono. "Coapt has established itself as a market leader and innovator, and the company has steadily increased its product offerings and customer base. Coapt is now poised to expand its innovative product line and to move into new markets, particularly non-invasive aesthetics."

The company has introduced seven products into the market since 2002, and over 65,000 patients worldwide have received ENDOTINE(TM) implants in facial rejuvenation procedures. The Company's products are sold in over 41 countries.

Coapt Systems, founded in 2000 by a practicing plastic surgeon, designs, develops, manufactures, and markets bio absorbable implants that provide surgeons wit
'/>"/>